Dr. Eyal Kalo, R&D Director of Innocan Pharma, added "LPT-CBD demonstrates sustained pharmacokinetics and has shown efficacy in multiple animal models of chronic pain. We are extremely proud of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback